http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107854455-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0d44338a9983e0302c286cb9d319ff9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 |
| filingDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685253980351b754f8ecf6867157fabf |
| publicationDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107854455-A |
| titleOfInvention | Dysidavarone A are preparing the application in raising red blood cell medicine |
| abstract | The present invention relates to a kind of new applications of compound Dysidavarone A in pharmaceutical field.The present invention relates to applications of the Dysidavarone A in the medicine for preparing rise red blood cell.Purposes of the Dysidavarone A of the present invention in the treatment low medicine thing of red blood cell is prepared belongs to first public, because framework types belong to brand-new framework types, and it is unexpectedly strong for the low inhibitory activity of red blood cell, in the absence of the possibility that any enlightenment is provided by other compounds, possess prominent substantive distinguishing features, while the preventing and treating low for red blood cell obviously has significant progress. |
| priorityDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219 |
Total number of triples: 18.